218 related articles for article (PubMed ID: 4628703)
41. A factor in guinea-pig serum with accelerating effect on immune immobilization of Treponema pallidum (IAF). Isolation, purification and differentiation from the known haemolytic complement components and from lysozyme.
Müller F; Segerling M
Immunology; 1974 Jul; 27(1):33-41. PubMed ID: 4604004
[TBL] [Abstract][Full Text] [Related]
42. Immune mechanisms of reversed type reaginic hypersensitivity.
Ishizaka K; Ishizaka T
J Immunol; 1969 Sep; 103(3):588-95. PubMed ID: 4185043
[No Abstract] [Full Text] [Related]
43. A method for preparing monospecific antisera to Cl esterase (Cls): microheterogeneity of purified Cls.
Nagaki K; Stroud RM
J Immunol; 1970 Jul; 105(1):162-9. PubMed ID: 4988888
[No Abstract] [Full Text] [Related]
44. [Inhibition of specific binding activity of guinea pig complement C3 by dithiothreitol].
Takahashi S; Tanaka K; Kono H; Takahashi M
Arerugi; 1972 Jan; 21(1):40-9. PubMed ID: 4623566
[No Abstract] [Full Text] [Related]
45. [Isolation and physical characterization of an alpha1-acid-glycoprotein from human serum (author's transl)].
Irurzun PL; Miranda MP
Sangre (Barc); 1975; 20(2):113-20. PubMed ID: 806981
[No Abstract] [Full Text] [Related]
46. Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly.
Nicholson A; Brade V; Lee GD; Shin HS; Mayer MM
J Immunol; 1974 Mar; 112(3):1115-23. PubMed ID: 4811964
[No Abstract] [Full Text] [Related]
47. Properdin factor D. II. Activation to D by properdin.
Fearon DT; Austen KF; Ruddy S
J Exp Med; 1974 Aug; 140(2):426-36. PubMed ID: 4211020
[TBL] [Abstract][Full Text] [Related]
48. Isolation and characterization of mouse serum alpha 1-antitrypsins.
Myerowitz RL; Chrambach A; Rodbard D; Robbins JB
Anal Biochem; 1972 Aug; 48(2):394-409. PubMed ID: 4627080
[No Abstract] [Full Text] [Related]
49. Properties of highly purified human properdin.
Ensky J; Hinz CF; Todd EW; Wedgwood RJ; Boyer JT; Lepow IH
J Immunol; 1968 Jan; 100(1):142-58. PubMed ID: 4169693
[No Abstract] [Full Text] [Related]
50. [Antigenicity of uvea constituents].
Urgancioglu M; Halpern B; Parlebas J; Rebeyrotte P
Rev Immunol (Paris); 1970; 34(3):85-97. PubMed ID: 4989941
[No Abstract] [Full Text] [Related]
51. Multiple nature of the third component of guinea-pig complement. I. Separation and characterization of three factors a, b, and c, essential for haemolysis.
Klein PG; Wellensiek HJ
Immunology; 1965 Jun; 8(6):590-603. PubMed ID: 5891628
[TBL] [Abstract][Full Text] [Related]
52. Dermonecrotic factor. I. Nature and properties of a dermonecrotic factor to guinea-pig skin found in human serum.
Ebringer A; Doyle AE; Harris GS
Br J Exp Pathol; 1969 Dec; 50(6):559-65. PubMed ID: 4983332
[TBL] [Abstract][Full Text] [Related]
53. Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.
Winkelstein JA; Shin HS; Wood WB
J Immunol; 1972 Jun; 108(6):1681-9. PubMed ID: 4402312
[No Abstract] [Full Text] [Related]
54. The C3-activator system: an alternate pathway of complement activation.
Götze O; Müller-Eberhard HJ
J Exp Med; 1971 Sep; 134(3 Pt 2):90s-108s. PubMed ID: 4105810
[No Abstract] [Full Text] [Related]
55. Fractionation of sera from operationally tolerant rats by DEAE cellulose chromatography; evidence that serum blocking factors are associated with IgG.
Wright PW; Hargreaves RE; Bernstein ID; Hellström I
J Immunol; 1974 Mar; 112(3):1267-70. PubMed ID: 4204561
[No Abstract] [Full Text] [Related]
56. Alternative pathway for the activation of complement in human serum. Formation and composition of the complex with cobra venom factor that cleaves the third component of complement.
Vogt W; Dieminger L; Lynen R; Schmidt G
Hoppe Seylers Z Physiol Chem; 1974 Feb; 355(2):171-83. PubMed ID: 4215726
[No Abstract] [Full Text] [Related]
57. The specificity of skin-sensitizing antibodies in the guinea-pig.
van Es L; den Harink H; Pondman KW
Clin Exp Immunol; 1970 May; 6(5):741-51. PubMed ID: 5477929
[TBL] [Abstract][Full Text] [Related]
58. Purification of human placental lactogen and its clinical application by single radial immunodiffusion.
Morikawa H; Mochizuki M; Tojo S
Endocrinol Jpn; 1971 Oct; 18(1):417-26. PubMed ID: 5003866
[No Abstract] [Full Text] [Related]
59. Activity levels of the alternate complement pathway in human pregnancy.
Brai M; Giambanco V; Waks H; Albano V; Osler AG
Acta Eur Fertil; 1974 Mar; 5(1):59-64. PubMed ID: 4844376
[No Abstract] [Full Text] [Related]
60. Fragments Ba and Bb derived from guinea pig factor B of the properdin system: purification, characterization, and biologic activities.
Hamuro J; Hadding U; Bitter-Suermann D
J Immunol; 1978 Feb; 120(2):438-44. PubMed ID: 74389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
